Results 31 to 40 of about 2,590,210 (272)

Association of intraoperative gross hematuria with acute kidney injury after cytoreductive surgery

Pleura and Peritoneum, 2022
–Early detection and treatment of postoperative acute kidney injury is essential.–How to prevent acute kidney injury after cytoreductive surgery is unclear.–Intraoperative hematuria is related to postoperative acute kidney injury.–Hematuria is easily ...
Mitani Yumi, Arai Yohei, Tomohiro Mitani, Gohda Yoshimasa, Yano Hideaki, Kondo Isao, Sakamoto Emi, Katagiri Daisuke, Hinoshita Fumihiko   +8 more
doaj   +1 more source

Evaluation of the relationship between lactacidemia and postoperative complications after surgery for peritoneal carcinomatosis [PDF]

Korean Journal of Anesthesiology, 2021
Background Cytoreductive surgery was developed as a treatment for peritoneal carcinomatosis. However, this surgery is associated with important complications.
Marta Soriano Hervás, Rosa Játiva-Porcar, Daniel Robles-Hernández, Anna Serra Rubert, Blanca Segarra, Cristina Oliva, Javier Escrig, José Antonio Llueca   +7 more
doaj   +1 more source

Neoadjuvant chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: a feasibility and safety study

World Journal of Surgical Oncology, 2019
Background Standard treatment for colorectal peritoneal carcinomatosis typically involves cytoreductive surgery, hyperthermic intraperitoneal chemotherapy (HIPEC), and if possible, postoperative adjuvant chemotherapy. However, a substantial percentage of
M. Leimkühler, P. H. J. Hemmer, A. K. L. Reyners, D. J. A. de Groot, R. J. van Ginkel, L. B. Been, G. H. de Bock, B. L. van Leeuwen   +7 more
doaj   +1 more source

Prognostic factors of malignant peritoneal mesothelioma: a retrospective study of 52 female patients

World Journal of Surgical Oncology, 2022
Background Prognosis in malignant peritoneal mesothelioma (MPM) remains poor, and the associated factors are unclear. Therefore, this study aimed to investigate the prognostic factors of MPM. Methods A total of 52 female MPM patients treated in 2012–2017
Jianting Ma, Shengzhi Zhang
doaj   +1 more source

Giant hepatic extra-gastrointestinal stromal tumor treated with cytoreductive surgery and adjuvant systemic therapy: A case report and review of literature

World Journal of Gastrointestinal Surgery, 2021
BACKGROUND Primary extra-gastrointestinal stromal tumors (E-GIST) of the liver are rare. The clinical presentation may range from asymptomatic to bleeding or manifestations of mass effect.
M. R. Fernandes, C. Ghezzi, T. Grezzana-Filho, F. Feier, I. Leipnitz, A. Chedid, C. Cerski, M. Chedid, C. Kruel   +8 more
semanticscholar   +1 more source

Cerebral edema in a patient following cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemoperfusion

World Journal of Surgical Oncology, 2006
Background Cytoreductive surgery and intraoperative, intraperitoneal hyperthermic chemoperfusion (HIPEC) is increasingly used to treat peritoneal surface metastases.
Stemmerman Grant, Tobias Jonathan, Nair Rajalakshmi L, Lowy Andrew M   +3 more
doaj   +1 more source

Cytoreductive surgery in ovarian cancer [PDF]

Cancer Imaging, 2007
As the overall prognosis for patients with ovarian cancer is poor, the management of this condition should be restricted to expert multi-disciplinary teams in gynaecological oncology. Apparent early stage ovarian cancer requires accurate and complete staging so that potential sites for metastases are not missed.
Pomel, Christophe, Jeyarajah, Arjun, Oram, David, Shepherd, John, Milliken, David, Dauplat, Jacques, Reynolds, Karina   +6 more
openaire   +2 more sources

Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

International Journal of Gynecological Cancer, 2020
Background The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery improves recurrence-free and overall survival in patients with FIGO stage III ovarian cancer who are ineligible for primary cytoreductive ...
S. Koole, R. V. van Stein, K. Sikorska, D. Barton, L. Perrin, D. Brennan, O. Zivanovic, B. Mosgaard, A. Fagotti, Pierre-Emmanuel Colombo, G. Sonke, W. J. V. Driel   +11 more
semanticscholar   +1 more source

Efficacy of Surgical Treatment of Peritoneal Carcinomatosis in Patients with Colorectal Cancer

Galician Medical Journal, 2016
Colorectal cancer is one of the most common types of cancer in Ukraine. Prognosis for patients with peritoneal carcinomatosis is unfavorable, and life expectancy is typically less than 6 months.
T G Fetsych, A P Revura
doaj   +1 more source

Evaluation of Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Stage III Epithelial Ovarian Cancer

JAMA Network Open, 2020
Key Points Question Is the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to primary cytoreductive surgery (PCS) associated with better outcomes for patients with stage III epithelial ovarian cancer?
Z. Lei, Yue Wang, Jiahong Wang, Ke Wang, Jun Tian, Ying Zhao, Lipai Chen, Jin Wang, Jiali Luo, M. Jia, Hong-sheng Tang, Qingjun He, Quanxing Liao, Xiansheng Yang, T. Guan, Li Wang, S. Cui   +16 more
semanticscholar   +1 more source